In 2016, Tessem et al. used the same sample set to assess the metabolic profile of PCa driven by the TMPRSS2-ERG gene fusion [55], which is associated with higher risk of progression and aggressiveness of disease. This evidence concerns the gene ERG and posterior cortical atrophy.